Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BL-5010 for seborrheic keratosis removal
NL-OMON33988Active, not recruiting
- Sponsor
- BioLineRx Ltd.
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of BL-5010 in seborrheic keratosis (SK), sponsored by BioLineRx Ltd. Primary endpoint: Safety of BL-5010 in seborrheic keratosis. Started Oct 2009; status: active, not recruiting.
02
Drugs
BL-5010
03
Conditions
seborrheic keratosis (SK)
Beyond the preview
Go deeper on NL-OMON33988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33988.